Approval · Notice of Compliance 9544 · 2008
RAN-RAMIPRIL: Notice of Compliance 9544
Issued May 9, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9544
- Date
- May 9, 2008
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin converting enzyme inhibitor
- Canadian reference product
- ALTACE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-RAMIPRIL | 02310503 | Marketed |
| RAN-RAMIPRIL | 02310511 | Marketed |
| RAN-RAMIPRIL | 02310538 | Marketed |
| RAN-RAMIPRIL | 02310546 | Marketed |